For medical device innovators, the leap from prototype to regulatory submission is filled with risk. Even a well-engineered product can be rejected if the clinical validation isn’t designed for FDA, CE, or MHRA expectations. That’s why more device sponsors are turning to Parameters Lab. We don’t just execute trials; we architect them for success. 1. Protocols That Mirror Regulatory Expectations Every study we design begins with a regulatory reverse-engineering process. We

The European market represents a major opportunity for developers of blood pressure (BP) monitoring technology, but with great opportunity comes great scrutiny. Navigating the path to CE marking under the EU’s rigorous Medical Device Regulation (MDR 2017/745) requires a level of preparation and precision. Success now hinges on providing a higher caliber of clinical evidence, more robust post-market surveillance plans, and more comprehensive technical documentation than ever b

Introduction The emergence of cuffless blood pressure (BP) monitors has opened new frontiers in cardiovascular and metabolic health monitoring. These wearable and often continuous monitoring systems promise to transform hypertension management and preventive care by offering convenience, real-time data, and better patient adherence. However, without rigorous clinical validation, these innovations cannot achieve regulatory clearance—or clinical trust. Unlike traditional cuff-b